Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
116 Results Found
Beaver Dam Community Hospital UDI Capture Work Group Case Study
Case Studies
A UDI Capture Work Group Case Study at the Beaver Dam Community Hospitals, Inc.
Business Case for the UDI Presentation
Toolkits/Methodology
With significant pressures on hospitals and healthcare systems, it is incumbent upon those who recognize the benefits of UDI to build the business case for UDI adoption in the healthcare delivery e
Business Case for the UDI Work Group Report
Guides/Reports
Overview:
The Business Case for the UDI work group, a formal work group of the Association for Healthcare Resource & Materials Management’s (AHRMM) Learning UDI Community (LUC) is com
FMOL Health System UDI Capture Work Group Case Study
Case Studies
WORK GROUP TITLE:
UDI Capture Work Group
CASE STUDY PARTICIPANTS:
FDA updates sterilization standards for medical device makers
The Food and Drug Administration the week of July 24 updated its recognized consensus standards database for medical devices to advance innovation in medical device sterilization processes.
AHA urges EPA to ensure ethylene oxide standards don’t disrupt supply chain
Commenting yesterday on the Environmental Protection Agency’s proposed standards for ethylene oxide use to sterilize medical devices, AHA encouraged the agency to give commercial sterilization facilities sufficient time to comply with any final standards to protect access to safe and sterile medical devices for patient care.
EPA sets 2024 date for ethylene oxide emissions rule; extends comment period to June 27
The Environmental Protection Agency May 30 announced its intent to finalize by March 1, 2024, new rules governing emissions from ethylene oxide, the gas widely used in medical sterilization facilities.
FDA releases transition plans for medical device enforcement, authorization after COVID-19 public health emergency
The Food and Drug Administration today released final guidance for transitioning medical device enforcement policies and emergency use authorizations established during the COVID-19 public health emergency to normal operations.
FDA updates EUAs for COVID-19 antigen tests, alerts providers to device recall and shortage
The FDA revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require updates to product labeling regarding serial testing, and designated the recall of 60,500 filters used in breathing systems a Class I recall.